We validated our findings using an expanded panel of AML cell lines and confirmed STAT5A expression is significantly higher at both the RNA and protein level in AMKL compared to non-AMKL, with the exception of HEL cells (positive control) that harbor a JAK2V617F mutation (Fig. 6c, e). This evidence concerns the gene STAT5A and acute myeloid leukemia.